| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Bhmt - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502161 | 1 kit | ORIGENE TECHNOLOGIES |
| Bhmt2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502162 | 1 kit | ORIGENE TECHNOLOGIES |
| BHMT Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH303148 | 10 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR561232 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR561978 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR562195 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR562440 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR562490 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR562625 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR562626 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR563000 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR563001 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIES | CR560106 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIES | CR560087 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIES | CR562471 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIES | CR562480 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIES | CR562481 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIES | CR562489 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIES | CR562628 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIES | CR560300 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral-Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIES | CR566311 | n/a | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Carcinoma of ovary from ORIGENE TECHNOLOGIES | CR560093 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Carcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR559066 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Carcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR560246 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Carcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR560582 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Carcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR561205 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Carcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR561307 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary: bilateral; Carcinosarcoma of ovary from ORIGENE TECHNOLOGIES | CR560449 | 5 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 13 (CCL13 / MCP-4) from ORIGENE TECHNOLOGIES | TP723841 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 2 (CCL2 / MCP-1) from ORIGENE TECHNOLOGIES | TP723718 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 7 (CCL7 / MCP-3) from ORIGENE TECHNOLOGIES | TP723823 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 8 (CCL8 / MCP-2) from ORIGENE TECHNOLOGIES | TP723788 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 22 (CCL22 / MDC) from ORIGENE TECHNOLOGIES | TP723815 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 28 (CCL28 / MEC) from ORIGENE TECHNOLOGIES | TP723812 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 3 (CCL3 / MIP-1alpha) from ORIGENE TECHNOLOGIES | TP723800 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 20 (CCL20 / MIP-3alpha), transcript variant 1 from ORIGENE TECHNOLOGIES | TP723810 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 19 (CCL19 / MIP-3beta) from ORIGENE TECHNOLOGIES | TP723793 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 15 (CCL15 / MIP-1delta) from ORIGENE TECHNOLOGIES | TP723840 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 23 (CCL23 / MPIF-1), transcript variant CKbeta8 from ORIGENE TECHNOLOGIES | TP723835 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 23 (CCL23 / MPIF-1), transcript variant CKbeta8 from ORIGENE TECHNOLOGIES | TP723836 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 5 (CCL5 / RANTES) from ORIGENE TECHNOLOGIES | TP723778 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 17 (CCL17 / TARC) from ORIGENE TECHNOLOGIES | TP723729 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 25 (CCL25 / TECK), transcript variant 1 from ORIGENE TECHNOLOGIES | TP723834 | 10 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 14 (CCL14), transcript variant 1 from ORIGENE TECHNOLOGIES | TP317672 | 20 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 15 (CCL15), transcript variant 1 from ORIGENE TECHNOLOGIES | TP312975 | 20 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 15 (CCL15), transcript variant 2 from ORIGENE TECHNOLOGIES | TP319289 | 20 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 4 (CCL4), transcript variant 1 from ORIGENE TECHNOLOGIES | TP310481 | 20 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 15 (CCL15), transcript variant 1. from ORIGENE TECHNOLOGIES | TP723318 | 25 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 20 (CCL20), transcript variant 1. from ORIGENE TECHNOLOGIES | TP723313 | 20 ug | ORIGENE TECHNOLOGIES |
| Human chemokine (C-C motif) ligand 25 (CCL25), transcript variant 1. from ORIGENE TECHNOLOGIES | TP723433 | 20 ug | ORIGENE TECHNOLOGIES |